Buy Crypto Markets Spot FuturesBTC Earn Event Centre Rewards Hub

Lantern Pharma Inc. (LTRN)

NASDAQ

$1.71

$--

(0.00%)

Pre-Market

Lantern Pharma Inc. (LTRN) Live Price Chart

Last updated: ⁦2026-09-16 09:46:20⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Lantern Pharma Inc. (LTRN) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $1.71, with a market capitalisation of $21.86M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.11 to $4.70. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$21.86M
Open	$1.71
Day's High	$24.84
Day's Low	$1.11
Previous Close	$1.71
Volume	126.66K
Average Volume	139.23K
P/E Ratio	--
52-Week High	$4.70
52-Week Low	$1.11
Dividend Yield	--
Earnings Date	--

Lantern Pharma Inc. (LTRN) Pre-Market Stock Price

Lantern Pharma Inc. (LTRN) is trading at $1.66 in pre-market trading as of 2026-09-15 23:31:00, down 3.22% ($0.05) from the previous close of $1.71

Pre-market trading shows how investors are pricing LTRN before the regular session opens. The current pre-market price is below the previous close, indicating cautious early trading sentiment.

Lantern Pharma Inc. (LTRN) 7-Day Stock Price Change

Over the past seven days, Lantern Pharma Inc. (LTRN) moved from $1.91 to $1.71, representing a decline of 10.24% ($0.20).

The stock traded between $1.66 and $2.01 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.

The average daily volume was 153.37 thousand shares, up versus the previous seven-day period, indicating higher trading activity.

LTRN 52-Week Price Position

Position in Range: 16.7%

52W Low$1.11

52W High$4.70

LTRN is currently trading at $1.71, placing it 16.7% of the way from its 52-week low of $1.11 to its 52-week high of $4.70. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Lantern Pharma Inc. (LTRN)?

Lantern Pharma Inc is a biopharmaceutical company focused on developing oncology drug candidates using its artificial intelligence platform. The company utilizes its proprietary RADR platform to identify, develop, and advance small molecule therapies and antibody-drug conjugates, with a pipeline that includes three lead small molecule drug candidates (LP-300, LP-184, and LP-284) targeting solid tumors and blood cancers. It also advances programs through its subsidiary focused on central nervous system and brain cancers.

Lantern Pharma Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	16
Exchange	NASDAQ
Company Website	https://www.lanternpharma.com

How to Buy Lantern Pharma Inc. (LTRN) Stock on MEXC

Eligible investors can buy real shares of Lantern Pharma Inc. (LTRN) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for LTRN and Place Your Order

Open the RealStocks trading page and search for LTRN. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Lantern Pharma Inc. (LTRN) stock price today?

Lantern Pharma Inc. (LTRN) is currently trading at $ 1.71, unchanged from the previous close of $ 1.71. Intraday prices update in real time during regular trading hours.

2.Is LTRN stock going up or down today?

As of 2026-09-15 23:31:00, LTRN is trading at $ 1.71, unchanged from its previous close of $ 1.71. The stock has traded between $ 1.11 and $ 24.84 during today’s regular session. Past price movements do not guarantee future results.

3.What is LTRN pre-market price?

As of 2026-09-15 23:31:00, LTRN is trading at $ 1.66 in pre-market trading, down 3.22% ($0.05) from the previous close of $ 1.71. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is LTRN after-hours price?

As of 2026-09-15 23:31:00, LTRN is trading at $ 1.73 in after-hours trading, up 1.17% ($0.02) from the regular-session close of $ 1.71. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is LTRN stock trading now?

LTRN trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does LTRN sit relative to its 52-week high and low?

Over the past 52 weeks, LTRN has traded between a low of $ 1.11 and a high of $ 4.70. At $ 1.71, the stock is positioned 16.7% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Lantern Pharma Inc. in?

Lantern Pharma Inc. (LTRN) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Lantern Pharma Inc.'s market capitalisation and where is it listed?

Lantern Pharma Inc. is listed on the NASDAQ exchange with a market capitalisation of $ 21.86M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is LTRN valued in terms of P/E ratio and EPS?

LTRN trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -1.46. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Lantern Pharma Inc. pay a dividend?

Lantern Pharma Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.